Diagnostic challenges and clinical characteristics of hepatitis e virus-associated guillain-Barré syndrome

JAMA Neurology

Volumn 74, Issue 1, 2017, Pages 26-33

  Stevens, Olivier ^a   Claeys, Kristl G ^a,b   Poesen, Koen ^a,b   Saegeman, Veroniek ^a,b   Van Damme, Philip ^a,b,c  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b KU LEUVEN UNIVERSITY OF LEUVEN   (Belgium)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGED; ARTICLE; BELGIAN; COHORT ANALYSIS; CROSS REACTION; CYTOMEGALOVIRUS; ENZYME IMMUNOASSAY; EPSTEIN BARR VIRUS; FEMALE; GUILLAIN BARRE SYNDROME; HEPATITIS E; HUMAN; IMMUNOBLOTTING; IMMUNOLOGY TEST KIT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYCOPLASMA PNEUMONIAE; POLYMERASE CHAIN REACTION SYSTEM; PREVALENCE; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BLOOD; COMPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GUILLAIN-BARRE SYNDROME; HEPATITIS E VIRUS; IMMUNOLOGY; METABOLISM; PATHOGENICITY; VIROLOGY;

ADULT; AGED; ALANINE TRANSAMINASE; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GUILLAIN-BARRE SYNDROME; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED;

EID: 85011382720     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2016.3541     Document Type: Article

References (71)

1. van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol. 2008;7 (10):939-950.
2. Ang CW, De Klerk MA, Endtz HP, et al. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b antibodies in rabbits. Infect Immun. 2001;69(4): 2462-2469.
3. Griffin JW, Li CY, Ho TW, et al. Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol. 1996;39(1):17-28.
4. Halstead SK, O'Hanlon GM, Humphreys PD, et al. Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy. Brain. 2004;127(pt 9):2109-2123.
5. Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain. 2002;125(pt 12): 2591-2625.
6. Yuki N, Yoshino H, Sato S, Ohno T, Miyatake T. An acute axonal form of Guillain-Barré syndrome with antibodies against gangliosides GM1 and GD1b-a case report [in Japanese]. Rinsho Shinkeigaku. 1990;30(9):989-993.
7. Yuki N. Anti-ganglioside antibody and neuropathy: review of our research. J Peripher Nerv Syst. 1998;3(1):3-18.
8. Yuki N, Yamada M, Koga M, et al. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol. 2001;49(6):712-720.
9. Yuki N, Susuki K, Koga M, et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proc Natl Acad Sci U S A. 2004;101(31):11404-11409.
10. Hadden RD, Karch H, Hartung HP, et al; Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology. 2001;56(6):758-765.
11. Jacobs BC, Rothbarth PH, van der Meché FG, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology. 1998;51(4):1110-1115.
12. Kamani P, Baijal R, Amarapurkar D, et al. Guillain-Barre syndrome associated with acute hepatitis E. Indian J Gastroenterol. 2005;24(5):216.
13. Sood A, Midha V, Sood N. Guillain-Barré syndrome with acute hepatitis E. Am J Gastroenterol. 2000;95(12):3667-3668.
14. Loly JP, Rikir E, SeivertM, et al. Guillain-Barré syndrome following hepatitis E.World J Gastroenterol. 2009;15(13):1645-1647.
15. Cronin S, McNicholas R, Kavanagh E, Reid V, O'Rourke K. Anti-glycolipid GM2-positive Guillain-Barre syndrome due to hepatitis E infection. Ir J Med Sci. 2011;180(1):255-257.
16. Kumar R, Bhoi S, Kumar M, Sharma B, Singh BM, Gupta BB. Guillain-Barré syndrome and acute hepatitis: a rare association. J Indian Acad Clin Med. 2002;3(4):389-391.
17. Maurissen I, Jeurissen A, Strauven T, Sprengers D, De Schepper B. First case of anti-ganglioside GM1-positive Guillain-Barré syndrome due to hepatitis E virus infection. Infection. 2012;40(3): 323-326.
18. Tse ACT, Cheung RTF, Ho SL, Chan KH. Guillain-Barré syndrome associated with acute hepatitis E infection. J Clin Neurosci. 2012;19(4): 607-608.
19. Scharn N, Ganzenmueller T,Wenzel JJ, Dengler R, Heim A,Wegner F. Guillain-Barré syndrome associated with autochthonous infection by hepatitis E virus subgenotype 3c. Infection. 2014;42 (1):171-173.
20. Sharma B, Nagpal K, Bakki Sannegowda R, Prakash S. Hepatitis E with Gullain-Barré syndrome: still a rare association. J Neurovirol. 2013;19(2):186-187.
21. Kamar N, Bendall RP, Peron JM, et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis. 2011;17(2):173-179.
22. Del Bello A, Arné-Bes MC, Lavayssière L, Kamar N. Hepatitis E virus-induced severemyositis. J Hepatol. 2012;57(5):1152-1153.
23. Santos L, Mesquita JR, Rocha Pereira N, et al. Acute hepatitis E complicated by Guillain-Barré syndrome in Portugal, December 2012-a case report. Euro Surveill. 2013;18(34):3-6.
24. Comont T, Bonnet D, Sigur N, et al. Acute hepatitis E infection associated with Guillain-Barré syndrome in an immunocompetent patient [in French]. Rev Med Interne. 2014;35(5):333-336.
25. Chen X-D, Zhou Y-T, Zhou J-J,Wang Y-W, Tong D-M. Guillain-Barré syndrome and encephalitis/encephalopathy of a rare case of Northern China acute severe hepatitis E infection. Neurol Sci. 2014;35(9):1461-1463.
26. Higuchi M-A, Fukae J, Tsugawa J, et al. Dysgeusia in a patient with Guillain-Barré syndrome associated with acute hepatitis E: a case report and literature review. Intern Med. 2015;54(12):1543-1546.
27. Perrin HB, Cintas P, Abravanel F, et al. Neurologic disorders in immunocompetent patients with autochthonous acute hepatitis E. Emerg Infect Dis. 2015;21(11):1928-1934.
28. Bandyopadhyay D, Ganesan V, Choudhury C, et al. Two uncommon causes of Guillain-Barré syndrome: hepatitis E and Japanese encephalitis. Case Rep Neurol Med. 2015;2015:759495.
29. Woolson KL, Forbes A, Vine L, et al. Extra-hepatic manifestations of autochthonous hepatitis E infection. Aliment Pharmacol Ther. 2014; 40(11-12):1282-1291.
30. Geurtsvankessel CH, Islam Z, Mohammad QD, Jacobs BC, Endtz HP, Osterhaus ADME. Hepatitis E and Guillain-Barré syndrome. Clin Infect Dis. 2013; 57(9):1369-1370.
31. van den Berg B, van der Eijk AA, Pas SD, et al. Guillain-Barré syndrome associated with preceding hepatitis E virus infection. Neurology. 2014;82(6): 491-497.
32. Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev. 2014; 27(1):116-138.
33. Pérez-Gracia MT, Suay B, Mateos-Lindemann ML. Hepatitis E: an emerging disease. Infect Genet Evol. 2014;22:40-59.
34. Dalton HR, Hunter JG, Bendall RP. Hepatitis E. Curr Opin Infect Dis. 2013;26(5):471-478.
35. Fong F, Illahi M. Neuralgic amyotrophy associated with hepatitis E virus. Clin Neurol Neurosurg. 2009;111(2):193-195.
36. Rianthavorn P, Thongmee C, LimpaphayomN, Komolmit P, Theamboonlers A, Poovorawan Y. The entire genome sequence of hepatitis E virus genotype 3 isolated from a patient with neuralgic amyotrophy. Scand J Infect Dis. 2010;42(5):395-400.
37. van Eijk JJ, Madden RG, van der Eijk AA, et al. Neuralgic amyotrophy and hepatitis E virus infection. Neurology. 2014;82(6):498-503.
38. Dartevel A, Colombe B, Bosseray A, et al. Hepatitis E and neuralgic amyotrophy: five cases and review of literature. J Clin Virol. 2015;69:156-164.
39. SilvaM, Wicki B, Tsouni P, et al. Hepatitis E virus infection as a direct cause of neuralgic amyotrophy. Muscle Nerve. 2016;54(2):325-327.
40. Despierres L-A, Kaphan E, Attarian S, et al. Neurologic disorders and hepatitis E, France, 2010. Emerg Infect Dis. 2011;17(8):1510-1512.
41. Kejariwal D, Roy S, Sarkar N. Seizure associated with acute hepatitis E. Neurology. 2001;57(10):1935.
42. Mandal K, Chopra N. Acute transversemyelitis following hepatitis E virus infection. Indian Pediatr. 2006;43(4):365-366.
43. Sarkar P, Morgan C, Ijaz S. Transversemyelitis caused by hepatitis E: previously undescribed in adults [published online July 6, 2015]. BMJ Case Rep. doi:10.1136/bcr-2014-209031
44. Mengel AM, StenzelW, Meisel A, Büning C. Hepatitis E-induced severemyositis. Muscle Nerve. 2016;53(2):317-320.
45. Jha AK, Nijhawan S, Nepalia S, Suchismita A. Association of Bell's palsy with hepatitis E virus infection: a rare entity. J Clin Exp Hepatol. 2012;2(1): 88-90.
46. Yadav KK, Rohatgi A, Sharma SK, Kulshrestha M, Sachdeva S, Pardasani V. Oculomotor palsy associated with hepatitis E infection. J Assoc Physicians India. 2002;50(5):737.
47. Dixit VK, Abhilash VB, Kate MP, Jain AK. Hepatitis E infection with Bell's palsy. J Assoc Physicians India. 2006;54:418.
48. Belbezier A, Deroux A, Sarrot-Reynauld F, Larrat S, Bouillet L.Myasthenia gravis associated with acute hepatitis E infection in immunocompetent woman. Emerg Infect Dis. 2014; 20(5):908-910.
49. Thapa R, Mallick D, Biswas B. Pseudotumor cerebri in childhood hepatitis E virus infection. Headache. 2009;49(4):610-611.
50. Dalton HR, Kamar N, van Eijk JJJ, et al. Hepatitis E virus and neurological injury. Nat Rev Neurol. 2016;12(2):77-85.
51. Kamar N, Marion O, Abravanel F, Izopet J, Dalton HR. Extrahepatic manifestations of hepatitis E virus. Liver Int. 2016;36(4):467-472.
52. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol. 1990;27(suppl):S21-S24.
53. Sejvar JJ, Kohl KS, Gidudu J, et al; Brighton Collaboration GBSWorking Group. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29(3):599-612.
54. Van der Meché FG, Van Doorn PA, Meulstee J, Jennekens FG; GBS-Consensus Group of the Dutch Neuromuscular Research Support Centre. Diagnostic and classification criteria for the Guillain-Barré syndrome. Eur Neurol. 2001;45(3): 133-139.
55. Wakerly BR, Uncini A, Yuki N; GBS Classification Group. Guillain-Barré and Miller Fisher syndromes-new diagnostic classification. Nat Rev Neurol. 2014;10(9):537-544.
56. Uncini A, Yuki N. Sensory Guillain-Barré syndrome and related disorders: an attempt at systematization. Muscle Nerve. 2012;45(4):464-470.
57. Nagashima T, Koga M, OdakaM, Hirata K, Yuki N. Continuous spectrum of pharyngeal-cervicalbrachial variant of Guillain-Barré syndrome. Arch Neurol. 2007;64(10):1519-1523.
58. Ito M, Matsuno K, Sakumoto Y, Hirata K, Yuki N. Ataxic Guillain-Barré syndrome and acute sensory ataxic neuropathy form a continuous spectrum. J Neurol Neurosurg Psychiatry. 2011;82(3):294-299.
59. Wakerley BR, Yuki N. Pharyngeal-cervicalbrachial variant of Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry. 2014;85(3):339-344.
60. Wakerley BR, Yuki N. Polyneuritis cranialis: oculopharyngeal subtype of Guillain-Barré syndrome. J Neurol. 2015;262(9):2001-2012.
61. Susuki K, Koga M, Hirata K, Isogai E, Yuki N. A Guillain-Barré syndrome variant with prominent facial diplegia. J Neurol. 2009;256(11):1899-1905.
62. Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial of prednisolone in acute polyneuropathy. Lancet. 1978;2(8093):750-753.
63. Hadden RD, Cornblath DR, Hughes RA, et al; Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Ann Neurol. 1998;44(5): 780-788.
64. Bruffaerts R, Yuki N, Damme PV, et al. Acute ataxic neuropathy associated with hepatitis E virus infection. Muscle Nerve. 2015;52(3):464-465.
65. Oomes PG, van der Meché FG, Kleyweg RP; Dutch Guillain-Barré Study Group. Liver function disturbances in Guillain-Barré syndrome: a prospective longitudinal study in 100 patients. Neurology. 1996;46(1):96-100.
66. Dimachkie MM, Barohn RJ. Guillain-Barré syndrome and variants. Neurol Clin. 2013;31(2):491-510.
67. Van Hoecke F, Van Maerken T, De Boulle M, et al. Hepatitis E seroprevalence in east and west Flanders, Belgium. Acta Gastroenterol Belg. 2012;75 (3):322-324.
68. Izopet J, Labrique AB, Basnyat B, et al. Hepatitis E virus seroprevalence in three hyperendemic areas: Nepal, Bangladesh and southwest France. J Clin Virol. 2015;70:39-42.
69. Hyams C, Mabayoje DA, Copping R, et al. Serological cross reactivity to CMV and EBV causes problems in the diagnosis of acute hepatitis E virus infection. J Med Virol. 2014;86(3):478-483.
70. Fogeda M, de Ory F, Avellón A, Echevarría JM. Differential diagnosis of hepatitis E virus, cytomegalovirus and Epstein-Barr virus infection in patients with suspected hepatitis E. J Clin Virol. 2009;45(3):259-261.
71. Ghinoiu M, Naveau S, Barri-Ova N, Thaury J, Grangeot-Keros L, Perlemuter G. Acute hepatitis E infection associated with a false-positive serology against Epstein-Barr virus. Eur J Gastroenterol Hepatol. 2009;21(12):1433-1435.